logo

Shariah compliance overview

Not Halal

Bicara Therapeutics Inc. Common Stock (BCAX) is currently classified as Not Halal by Akinda Shariah screening (AAOIFI-aligned methodology).

About Bicara Therapeutics Inc. Common Stock

Bicara Therapeutics Inc., a biopharmaceutical firm in the clinical development phase, is headquartered in Boston, Massachusetts. Established in 2018, the company specializes in creating innovative, dual-action treatments specifically for solid tumors.

Bicara Therapeutics Inc. Common Stock (BCAX) operates in the Healthcare sector, in the Biotechnology industry.

Why it is not classified as halal: it does not pass these screens: Business Activity, Interest-bearing securities and assets.

Business Activity
100.00%Limit 5%Fail
Interest-bearing debt
0.00%Limit 30%Pass
Interest-bearing securities and assets
36.55%Limit 30%Fail
Dividend purification
100.00%Share of dividends to give to charityPurification calculator

Last updated: Oct 22, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.

Please login to access this content

Key stats

Please login to access this content

Please login to access this content

Company Profile

Please login to access this content

Frequently asked questions

Quick answers about Bicara Therapeutics Inc. Common Stock (BCAX). Current Akinda screening label: Not Halal.